NCT01039636View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

December 31, 2010

Conditions
Transfusional Iron OverloadBeta-thalassemia
Interventions
DRUG

FBS0701

Oral FBS0701 for 7 days at one of the following doses: 3 mg/kg/day or 8 mg/kg/day or 16 mg/kg/day or 32 mg/kg/day or 40 mg/kg/day

Trial Locations (5)

10700

Siriraj Hospital, Mahidol University, Bangkok

19104

Children's Hospital of Philadelphia, Philadelphia

94609

Children's Hospital of Oakland, Oakland

02115

Children's Hospital of Boston, Boston

Unknown

Royal Adelaide Hospital, Adelaide

Sponsors
All Listed Sponsors
lead

FerroKin BioSciences, Inc.

INDUSTRY